TLR4/MyD88 expression patterns and novel genetic variants: association with aggressive clinicopathological features in colorectal cancer

BackgroundToll-like receptor 4 (TLR4) and myeloid differentiation factor 88 (MyD88) signaling play a critical role in colorectal cancer (CRC) development. Despite extensive research, the relationship between genetic variations and protein expression patterns during adenoma-carcinoma progression rema...

Full description

Saved in:
Bibliographic Details
Main Authors: Thai Tra Dang, Viet Nhat Pham, Ngoc Dung Tran, Thu Hang Ngo, Van Mao Can, Huy Hoang Nguyen, Thi Xuan Nguyen, Thanh Chung Dang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1568729/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839635714482896896
author Thai Tra Dang
Thai Tra Dang
Viet Nhat Pham
Ngoc Dung Tran
Thu Hang Ngo
Van Mao Can
Huy Hoang Nguyen
Thi Xuan Nguyen
Thanh Chung Dang
author_facet Thai Tra Dang
Thai Tra Dang
Viet Nhat Pham
Ngoc Dung Tran
Thu Hang Ngo
Van Mao Can
Huy Hoang Nguyen
Thi Xuan Nguyen
Thanh Chung Dang
author_sort Thai Tra Dang
collection DOAJ
description BackgroundToll-like receptor 4 (TLR4) and myeloid differentiation factor 88 (MyD88) signaling play a critical role in colorectal cancer (CRC) development. Despite extensive research, the relationship between genetic variations and protein expression patterns during adenoma-carcinoma progression remains poorly understood.MethodsWe conducted a cross-sectional study of 176 CRC patients and 131 adenoma patients. Inclusion criteria required histologically confirmed primary colorectal tumors with adequate tissue content (≥30% tumor cells). TLR4 and MyD88 protein expression was evaluated using immunohistochemistry with standardized scoring systems. DNA sequencing identified genetic variants in TLR4 and MyD88 genes. Multivariate analyses assessed associations between protein expression, genetic variants, and clinicopathological features.ResultsTLR4 expression was significantly higher in CRC compared to adenomas (66.5% vs 30.5%, p<0.001), with MyD88 showing widespread expression in both groups (CRC: 97.2%, adenoma: 95.4%). We identified novel variants in TLR4 (9:117713042) and MyD88 (rs138284536), significantly associated with increased CRC risk (OR=8.92, 95% CI: 1.14-69.95, p=0.037 and OR=20.01, 95% CI: 4.72-84.83, p<0.001, respectively). The MyD88 variant correlated with aggressive features including mucinous histology (43.5% vs 22.7%, p=0.036), advanced pT stage (29.6% vs 13.2%, p=0.044), and perineural invasion (61.5% vs 22.1%, p=0.004). Combined TLR4/MyD88 scores ≥5 significantly predicted lymph node metastasis (42.9% vs 28.3%, p=0.046) and high-grade tumor budding (p=0.002).ConclusionsOur study identifies distinct TLR4/MyD88 expression patterns in CRC progression and novel genetic variants associated with aggressive tumor features. These molecular alterations may serve as potential biomarkers for risk stratification and prognostic assessment in CRC patients, while offering promising targets for therapeutic intervention.
format Article
id doaj-art-15ee64bef92e4b2cb7fc25f5d6af636f
institution Matheson Library
issn 2234-943X
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-15ee64bef92e4b2cb7fc25f5d6af636f2025-07-09T04:12:57ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-07-011510.3389/fonc.2025.15687291568729TLR4/MyD88 expression patterns and novel genetic variants: association with aggressive clinicopathological features in colorectal cancerThai Tra Dang0Thai Tra Dang1Viet Nhat Pham2Ngoc Dung Tran3Thu Hang Ngo4Van Mao Can5Huy Hoang Nguyen6Thi Xuan Nguyen7Thanh Chung Dang8Department of Pathology and Forensic Medicine, Military Hospital 103, Vietnam Military Medical University, Hanoi, VietnamDepartment of Pathophysiology, Vietnam Military Medical University, Hanoi, VietnamInstitute of Biology, Vietnam Academy of Science and Technology, Hanoi, VietnamDepartment of Pathology and Forensic Medicine, Military Hospital 103, Vietnam Military Medical University, Hanoi, VietnamDepartment of Pathophysiology, Vietnam Military Medical University, Hanoi, VietnamDepartment of Pathophysiology, Vietnam Military Medical University, Hanoi, VietnamInstitute of Biology, Vietnam Academy of Science and Technology, Hanoi, VietnamInstitute of Biology, Vietnam Academy of Science and Technology, Hanoi, VietnamDepartment of Pathology and Forensic Medicine, Military Hospital 103, Vietnam Military Medical University, Hanoi, VietnamBackgroundToll-like receptor 4 (TLR4) and myeloid differentiation factor 88 (MyD88) signaling play a critical role in colorectal cancer (CRC) development. Despite extensive research, the relationship between genetic variations and protein expression patterns during adenoma-carcinoma progression remains poorly understood.MethodsWe conducted a cross-sectional study of 176 CRC patients and 131 adenoma patients. Inclusion criteria required histologically confirmed primary colorectal tumors with adequate tissue content (≥30% tumor cells). TLR4 and MyD88 protein expression was evaluated using immunohistochemistry with standardized scoring systems. DNA sequencing identified genetic variants in TLR4 and MyD88 genes. Multivariate analyses assessed associations between protein expression, genetic variants, and clinicopathological features.ResultsTLR4 expression was significantly higher in CRC compared to adenomas (66.5% vs 30.5%, p<0.001), with MyD88 showing widespread expression in both groups (CRC: 97.2%, adenoma: 95.4%). We identified novel variants in TLR4 (9:117713042) and MyD88 (rs138284536), significantly associated with increased CRC risk (OR=8.92, 95% CI: 1.14-69.95, p=0.037 and OR=20.01, 95% CI: 4.72-84.83, p<0.001, respectively). The MyD88 variant correlated with aggressive features including mucinous histology (43.5% vs 22.7%, p=0.036), advanced pT stage (29.6% vs 13.2%, p=0.044), and perineural invasion (61.5% vs 22.1%, p=0.004). Combined TLR4/MyD88 scores ≥5 significantly predicted lymph node metastasis (42.9% vs 28.3%, p=0.046) and high-grade tumor budding (p=0.002).ConclusionsOur study identifies distinct TLR4/MyD88 expression patterns in CRC progression and novel genetic variants associated with aggressive tumor features. These molecular alterations may serve as potential biomarkers for risk stratification and prognostic assessment in CRC patients, while offering promising targets for therapeutic intervention.https://www.frontiersin.org/articles/10.3389/fonc.2025.1568729/fullTLR4/MyD88 pathwaycolorectal carcinogenesisgenetic polymorphismsmolecular biomarkersclinicopathological featuresmicrosatellite instability
spellingShingle Thai Tra Dang
Thai Tra Dang
Viet Nhat Pham
Ngoc Dung Tran
Thu Hang Ngo
Van Mao Can
Huy Hoang Nguyen
Thi Xuan Nguyen
Thanh Chung Dang
TLR4/MyD88 expression patterns and novel genetic variants: association with aggressive clinicopathological features in colorectal cancer
Frontiers in Oncology
TLR4/MyD88 pathway
colorectal carcinogenesis
genetic polymorphisms
molecular biomarkers
clinicopathological features
microsatellite instability
title TLR4/MyD88 expression patterns and novel genetic variants: association with aggressive clinicopathological features in colorectal cancer
title_full TLR4/MyD88 expression patterns and novel genetic variants: association with aggressive clinicopathological features in colorectal cancer
title_fullStr TLR4/MyD88 expression patterns and novel genetic variants: association with aggressive clinicopathological features in colorectal cancer
title_full_unstemmed TLR4/MyD88 expression patterns and novel genetic variants: association with aggressive clinicopathological features in colorectal cancer
title_short TLR4/MyD88 expression patterns and novel genetic variants: association with aggressive clinicopathological features in colorectal cancer
title_sort tlr4 myd88 expression patterns and novel genetic variants association with aggressive clinicopathological features in colorectal cancer
topic TLR4/MyD88 pathway
colorectal carcinogenesis
genetic polymorphisms
molecular biomarkers
clinicopathological features
microsatellite instability
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1568729/full
work_keys_str_mv AT thaitradang tlr4myd88expressionpatternsandnovelgeneticvariantsassociationwithaggressiveclinicopathologicalfeaturesincolorectalcancer
AT thaitradang tlr4myd88expressionpatternsandnovelgeneticvariantsassociationwithaggressiveclinicopathologicalfeaturesincolorectalcancer
AT vietnhatpham tlr4myd88expressionpatternsandnovelgeneticvariantsassociationwithaggressiveclinicopathologicalfeaturesincolorectalcancer
AT ngocdungtran tlr4myd88expressionpatternsandnovelgeneticvariantsassociationwithaggressiveclinicopathologicalfeaturesincolorectalcancer
AT thuhangngo tlr4myd88expressionpatternsandnovelgeneticvariantsassociationwithaggressiveclinicopathologicalfeaturesincolorectalcancer
AT vanmaocan tlr4myd88expressionpatternsandnovelgeneticvariantsassociationwithaggressiveclinicopathologicalfeaturesincolorectalcancer
AT huyhoangnguyen tlr4myd88expressionpatternsandnovelgeneticvariantsassociationwithaggressiveclinicopathologicalfeaturesincolorectalcancer
AT thixuannguyen tlr4myd88expressionpatternsandnovelgeneticvariantsassociationwithaggressiveclinicopathologicalfeaturesincolorectalcancer
AT thanhchungdang tlr4myd88expressionpatternsandnovelgeneticvariantsassociationwithaggressiveclinicopathologicalfeaturesincolorectalcancer